Company: SXTPW
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001213900-25-043779
Chunk: 115

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 8
Chunk 115
---
 we also issued to the January 2025 Purchasers unregistered warrants (the “January 2025 Warrants”) to purchase
up to an aggregate of 408,621 shares of common stock at an exercise price of $3.855 per share. The January 2025 Warrants are exercisable
upon issuance and expire twenty-four months from the date of issuance.

The shares were offered pursuant to a “shelf”
registration statement on Form S-3 (Registration No. 333-280796), which was declared effective by the Securities and Exchange Commission
(the “SEC”) on July 18, 2024 as supplemented by a prospectus supplement dated January 28, 2025, filed with the SEC on January
30, 2025, and accompanying base prospectus, pursuant to Rule 424(b)(5) promulgated under the Securities Act of 1933, as amended (the “Securities
Act”).

H.C. Wainwright & Co., LLC (the “Placement
Agent”) acted as our exclusive placement agent in connection with the offering. Pursuant to the terms of the placement agent agreement,
we paid the Placement Agent a cash transaction fee equal to 7.5% of the aggregate gross cash proceeds in the offering and a management
fee equal to 1.0% of the aggregate gross cash proceeds in the offering. In addition, we paid for certain non-accountable expenses in the
amount of $15,000 and a clearing fee in the amount of $10,000. We also issued to the Placement Agent (or its designees) warrants to purchase
up to 15,325 shares of common stock (the “January 2025 Placement Agent Warrants”). The January 2025 Placement Agent Warrants
have an exercise price equal to $6.382 per share and are exercisable upon issuance and expire twenty-four months from the date of issuance.

24

The registered direct offering and the concurrent
private placement (collectively, the “January 2025 Offering”) closed on January 30, 2025, resulting in net proceeds of approximately
$804,346, after deducting estimated offering expenses paid by us, including the Placement Agent fees.

Pursuant to the January 2025 Securities Purchase
Agreement, within 45 days from the date of the January 2025 Securities Purchase Agreement, we were required to file a registration statement
with the SEC providing for the resale by the January 2025 Purchasers of the shares